Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and in silico analysis

  • Authors:
    • Saeedeh Salimi
    • Mahnaz Shahrakipour
    • Azam Hajizadeh
    • Mojgan Mokhtari
    • Mahdieh Mousavi
    • Batool Teimoori
    • Minoo Yaghmaei
  • View Affiliations

  • Published online on: December 21, 2016     https://doi.org/10.3892/br.2016.830
  • Pages: 237-241
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Uterine leiomyoma (UL) is the most common benign tumor causing considerable morbidity during the reproductive years in women. Cyclin D1 (CCND1) is a cell cycle regulatory protein that is required for the G1 phase, and increased expression levels of this protein may affect tumorigenesis. The present study aimed to assess the possible effect of the CCND1 G870A polymorphism on UL susceptibility. A total of 154 women with UL and 197 healthy women who were age‑, body mass index (BMI)‑ and ethnicity‑matched were genotyped for the CCND1 G870A (rs9344) polymorphism using the polymerase chain reaction‑restriction fragment length polymorphism method. The effects of G870A transition on the structure of mRNA and proteins of CCND1 was evaluated using bioinformatics tools. The frequency of the CCND1 870AA genotype was significantly higher in women with UL compared with the control subjects, and the risk of UL was 1.4‑fold higher in women with the AA genotype when compared with the GG genotype before and after adjusting for age, BMI, and ethnicity [odds ratio (OR), 1.4; 95% confidence interval (CI), 1.1‑2 (P=0.02)]. The frequency of CCND1 870GA genotype was not significantly different between the two groups. The frequency of the CCND1 870A allele was significantly higher in the women with UL when compared with the control subjects (57 vs. 48%; P=0.02). The in silico analysis revealed that the G870A transition may fundamentally alter the structure of the CCND1‑mRNA. Thus, the CCND1 870AA genotype was associated with UL susceptibility in a sample of women from the southeast of Iran.
View Figures
View References

Related Articles

Journal Cover

February-2017
Volume 6 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Salimi S, Shahrakipour M, Hajizadeh A, Mokhtari M, Mousavi M, Teimoori B and Yaghmaei M: Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and in silico analysis. Biomed Rep 6: 237-241, 2017
APA
Salimi, S., Shahrakipour, M., Hajizadeh, A., Mokhtari, M., Mousavi, M., Teimoori, B., & Yaghmaei, M. (2017). Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and in silico analysis. Biomedical Reports, 6, 237-241. https://doi.org/10.3892/br.2016.830
MLA
Salimi, S., Shahrakipour, M., Hajizadeh, A., Mokhtari, M., Mousavi, M., Teimoori, B., Yaghmaei, M."Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and in silico analysis". Biomedical Reports 6.2 (2017): 237-241.
Chicago
Salimi, S., Shahrakipour, M., Hajizadeh, A., Mokhtari, M., Mousavi, M., Teimoori, B., Yaghmaei, M."Cyclin D1 G870A polymorphism: Association with uterine leiomyoma risk and in silico analysis". Biomedical Reports 6, no. 2 (2017): 237-241. https://doi.org/10.3892/br.2016.830